These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15490984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, Sherman RA.
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [Abstract] [Full Text] [Related]

  • 5. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL, Stowe CD, Farrar HC, Blaszak CK, Blaszak RT.
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA.
    Perit Dial Int; 2000 Mar; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Mar; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM, Ranganathan D, Wallis SC, Varghese JM, Kark A, Lipman J, Roberts JA.
    Perit Dial Int; 2016 Mar; 36(4):415-20. PubMed ID: 26764340
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
    Elwell RJ, Frye RF, Bailie GR.
    Perit Dial Int; 2005 Mar; 25(4):380-6. PubMed ID: 16022096
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF.
    Perit Dial Int; 1999 Mar; 19(1):65-70. PubMed ID: 10201343
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ, Beringer PM, Aminimanizani A, Louie SG, Shapiro BJ, Jelliffe R, Gill MA.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
    Zhu W, Fang X, Zheng J, Ke Y, He Q, Cui T, Chen B, Tian L.
    Ren Fail; 2023 Dec; 45(2):2285873. PubMed ID: 38044852
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW, Bailie GR, Eisele G, Frye RF.
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.